Handling Deviation in the Pharmaceutical Industry.

Handling Deviation in the Pharmaceutical Industry.

1. What is Deviation in the Pharmaceutical Industry?
Deviation refers to any unexpected event during ongoing operations or activities that diverges from approved processes, procedures, instructions, specifications, or established standards. This can occur at any stage of the receipt, manufacturing, storage, sampling, testing of raw materials, intermediates, drug products, and packaging materials.

2. What are the Causes of Deviation?
Deviations in the pharmaceutical industry can arise from various factors, including:
Human error
Equipment failure
Raw material issues
Inadequate documentation
Unforeseen process variations

3. How Many Types of Deviation Are There in Pharma?
Deviations can be classified into three main types:
I. Critical Deviation: Significant impact on product quality or Good Manufacturing Practices (GMP) systems.
II. Major Deviation: Moderate to considerable impact on
product quality or GMP systems.
III Minor Deviation: Unlikely to have a detectable impact on product quality or GMP systems.

4. What are Examples of Deviation in Pharma?
I. Critical: Product mix-up, cross-contamination, missing process steps during manufacturing, filter integrity failures.
II. Major: Changes in mixing order, equipment breakdowns.
III. Minor: Non-compliance with room conditions, spillage of materials during dispensing.

5. What is the Deviation Investigation Procedure?
A structured approach for investigating deviations typicallyinvolves five steps:
I. Incident Discovery: Document the event within one business day.
II The 5 W’s: Address Who, What, When, Where, and Why.
III. Investigation: Collaborate with Subject Matter Experts (SMEs) and Quality Assurance (QA) to assess if a risk assessment is necessary.
IV. Root Cause Analysis (RCA): Utilize tools such as the Fishbone diagram to identify underlying causes.
V. Conclusion and Documentation: Finalize the investigation, referencing any related Corrective and Preventive Actions (CAPA).

6. What is the Difference Between Deviation and CAPA?
A deviation represents a departure from established procedures or standards, while CAPA refers to corrective actions taken to address the root causes of deviations. CAPA aims to prevent recurrence and is derived from thorough quality investigations.

7. How Do You Handle Pharma Deviation?
The handling of deviations follows a systematic flow:
I. Event Detection.
II. Deviation Categorization: Identify as Major/Minor and Planned/Unplanned.
III. Quality Risk Management (QRM): Initiate risk
assessments as needed.
IV. Root Cause Investigation
V. Implement CAPA

8. What is a Deviation Report?
A deviation report documents the details of the investigation, outcomes, corrective and preventive actions taken, and final conclusions.
By understanding and effectively managing deviations, pharmaceutical companies can ensure product quality, maintain compliance, and safeguard patient safety.